Skip to content
Wenlo
Sign in
← Markets

Neurocrine Biosciences, Inc.

Neurocrine Biosciences, Inc. (NBIX) — Form 144: Proposed sale of shares

144NBIXFiled Nov 10, 2026, 11:47 AM ET

About this filing

Neurocrine Biosciences, Inc. (NBIX) filed Form 144 (proposed sale of shares) with the SEC on Nov 10, 2026. Form 144 is notice that an insider or affiliate plans to sell shares.

Key facts

Seller
SANJAY KESWANI
Relationship
Former Affiliate
Shares to sell
53,614
Market value
$8,973,487.77
Approximate sale date
Nov 10, 2026
Broker
Morgan Stanley Smith Barney LLC Executive Financial Services
Acquired (1)
Nov 10, 2026 · Exercise of Options Under a Registered Plan
Acquired (2)
Nov 10, 2026 · Exercise of Options Under a Registered Plan
Acquired (3)
Nov 10, 2026 · Exercise of Options Under a Registered Plan
Acquired (4)
Nov 10, 2026 · Exercise of Options Under a Registered Plan

More NBIX filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.